Structure of the has operon promoter and regulation of hyaluronic acid capsule expression in group A Streptococcus

Molecular Microbiology

Volumn 28, Issue 2, 1998, Pages 343-353

  Albertí, Sebastián ^a,c   Ashbaugh, Cameron D ^a,b   Wessels, Michael R ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c UNIVERSITAT DE LES ILLES BALEARS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID;

ARTICLE; DNA SEQUENCE; GENE EXPRESSION REGULATION; GENE STRUCTURE; OPERON; PRIORITY JOURNAL; PROMOTER REGION; RECOMBINANT PLASMID; STREPTOCOCCUS GROUP A; TRANSCRIPTION REGULATION;

BACTERIAL CAPSULES; BACTERIAL PROTEINS; BASE SEQUENCE; CHLORAMPHENICOL O-ACETYLTRANSFERASE; GENES, BACTERIAL; GENES, REPORTER; GENETIC VECTORS; HYALURONIC ACID; MOLECULAR SEQUENCE DATA; OPERON; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); STREPTOCOCCUS PYOGENES;

ESCHERICHIA COLI; POSIBACTERIA; PROKARYOTA; STREPTOCOCCUS GROUP A; STREPTOCOCCUS SP. 'GROUP A'; TRIXIS;

EID: 0031892902     PISSN: 0950382X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2958.1998.00800.x     Document Type: Article

References (41)

1. Albertí, S., Ashbaugh, C.D., and Wessels, M.R. (1995) Polymorphism of the group A streptococcal chromosome upstream of the hyaluronic acid capsule synthesis genes. Abstracts of the 95th General Meeting of the American Society for Microbiology, p. 177 (abstract).
2. Ames, G.F., Prody, C., and Kustu, S. (1984) Simple, rapid, and quantitative release of periplasmic proteins by chloroform. J Bacteriol 140: 720-729.
3. Becker, C.G. (1964) Selection of group A streptococci rich in M protein from populations poor in M protein. Am J Pathol 44: 51-60.
4. Carapetis, J., Robins-Browne, R., Martin, D., Shelby-James, T., and Hogg, G. (1995) Increasing severity of invasive group A streptococcal disease in Australia: clinical and molecular epidemiological features and identification of a new virulent M-nontypeable clone. Clin Infect Dis 21: 1220-1227.
5. Chelsom, J., Halstensen, A., Tore, H., and Hoiby, E.A. (1994) Necrotising fasciitis due to group A streptococci in western Norway: incidence and clinical features. Lancet 344: 1111-1115.
6. Crater, D.L., and van de RiJn, I. (1995) Hyaluronic acid synthesis operon (has) expression in group A streptococci. J Biol Chem 270: 18452-18458.
7. Crater, D.L., Dougherty, B.A., and van de Rijn, I. (1995) Molecular characterization of hasC from an operon required for hyaluronic acid synthesis in group A streptococci. J Biol Chem 270: 28676-28680.
8. DeAngelis, P.L., Papaconstantinou, J., and Weigel, P.H. (1993) Molecular cloning, identification, and sequence of the hyaluronan synthase gene from group A Streptococcus pyogenes. J Biol Chem 268: 19181-19184.
9. Dougherty, B.A., and van de Rijn, I. (1993) Molecular characterization of hasB from an operon required for hyaluronic acid synthesis in group A streptococci. J Biol Chem 10: 7118-7124.
10. Dougherty, B.A., and van de Rijn, I. (1994) Molecular characterization of hasA from an operon required for hyaluronic acid synthesis in group A streptococci. J Biol Chem 269: 169-175.
11. Grafe, S., Ellinger, T., and Malke, H. (1996) Structural dissection and functional analysis of the complex promoter of the streptokinase gene from Streptococcus equisimilis H46A. Med Microbiol Immunol 185: 11-17.
12. Hoge, C.W., Schwartz, B., Talkington, D.F., Breiman, R.F., MacNeill, E.M., and Englender, S.J. (1993) The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. JAMA 269: 384-389.
13. Horinouchi, S., and Weisblum, B. (1982) Nucleotide sequence and functional map of pC194, a plasmid that specifies inducible chloramphenicol resistance. J Bacteriol 150: 815-825.
14. Hudson, M.C., and Stewart, G.C. (1986) Differential utilization of Staphylococcus aureus promoter sequences by Escherichia coli and Bacillus subtilis. Gene 48: 93-100.
15. Husman, L.K., Yung, D.-L, Hollingshead, S.K., and Scott, J.R. (1997) Role of putative virulence factors of Streptococcus pyogenes in mouse models of long-term throat colonization and pneumonia. Infect Immun 65: 1422-1430.
16. Ji, Y., McLandsborough, L., Kondagunta, A., and Cleary, P.P. (1996) C5a peptidase alters clearance and trafficking of group A streptococci by infected mice. Infect Immun 64: 503-510.
17. Johnson, D.R., Stevens, D.L., and Kaplan, E.L. (1992) Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis. J Infect Dis 166: 374-382.
18. Kapur, V., Majesky, M.W., Li, L.-L., Black, R.A., and Musser, J.M. (1993) Cleavage of interleukin 1β precursor to produce active IL-1β by a conserved extracellular cysteine protease from Streptococcus pyogenes. Proc Natl Acad Sci USA 90: 7676-7680.
19. Kovacic, R.T. (1987) The 0°C closed complexes between Escherichia coli RNA polymerase and two promoters, T7-A3 and lacUV. Biol Chem 262: 13654-13661.
20. Kushner, S.R. (1978) An improved method for transformation of Escherichia coli with ColE1-derived plasmids. In Genetic Engineering, Micosia, S. (ed.). New York: Elsevier/North Holland Biomedical Press.
21. Lee, P.K., and Schlievert, P.M. (1989) Group A streptococcal pyrogenic exotoxins: quantification and toxicity in an animal model of toxic shock syndrome-like illness. J Clin Microbiol 27: 1890-1892.
22. McIver, K.S., Heath, A.S., Green, B.D., and Scott, J.R. (1995) Specific binding of the activator Mga to promoter sequences of the emm and scpA genes in the group A streptococcus. J Bacteriol 177: 6619-6624.
23. Morrison, D.A., and Jaurin, R. (1990) Streptococus pneumoniae possesses canonical Escherichia coli (sigma 70) promoters. Mol Microbiol 4: 1143-1152.
24. Moses, A.E., Wessels, M.R., Zalcman, K., Albertí, S., Natanson-Yaron, S., Menes, T., et al. (1997) Relative contributions of hyaluronic acid capsule and M protein to virulence in a mucoid strain of group A Streptococcus. Infect Immun 65: 64-71.
25. O'Connor, S.P., and Cleary, P.P. (1987) In vivo Streptococcus pyogenes C5a peptidase activity: analysis using transposon-and nitrosoguanidine-induced mutants. J Infect Dis 156: 495-504.
26. Okada, N., Geist, R.T., and Caparon, M.G. (1993) Positive transcriptional control of mry regulates virulence in the group A streptococcus. Mol Microbiol 7: 893-903.
27. Perez-Casal, J., Caparon, M.G., and Scott, J.R. (1991) Mry, a trans-acting positive regulator of the M protein gene of Streptococcus pyogenes with similarity to the receptor proteins of two-component regulatory systems. J Bacteriol 173: 2617-2624.
28. Perez-Casal, J., Caparon, M.G., and Scott, J.R. (1992) Introduction of the emm6 gene into an emm-deletion strain of Streptococcus pyogenes restores its ability to resist phagocytosis. Res Microbiol 143: 549-558.
29. Perez-Casal, J., Price, J.A., Maguin, E., and Scott, J.R. (1993) An M protein with a single C repeat prevents phagocytosis of Streptococcus pyogenes: use of a temperature-sensitive shuttle vector to deliver homologous sequences to the chromosome of S. pyogenes. Mol Microbiol 8: 809-819.
30. Podbielski, A., Peterson, J.A., and Cleary, P. (1992) Surface protein-CAT reporter fusions demonstrate differential gene expression in the vir regulon of Streptococcus pyogenes. Mol Microbiol 6: 2253-2265.
31. Rothbard, S., and Watson, R.F. (1948) Variation occurring in group A streptococci during human infection. Progressive loss of M substance correlated with increasing susceptibility to bacteriostasis. J Exp Med 87: 521-533.
32. Sabelnikov, A.B., Greenberg, B., and Lacks, S.A. (1995) An extended -10 promoter alone directs transcription of the Dpnll operon of Streptococcus pneumonias. J Mol Biol 250: 144-155.
33. Schickor, P., Metzger, W., Werel, W., Lederer, H., and Neumann, H. (1990) Topography of intermediates in transcription initiation in E. coli. EMBO J 9: 2215-2220.
34. Schrager, H.M., Rheinwald, J.G., and Wessels, M.R. (1996) Hyaluronic acid capsule and the role of streptococcal entry into keratinocytes in invasive skin infection. J Clin Invest 98: 1954-58.
35. Shaw, W.V. (1975) Chloramphenicol acetyltransferase from chloramphenicol-resistant bacteria. Methods Enzymol 43: 737-755.
36. Stevens, D.L., Tanner, M.H., Winship, J., Swarts, R., Ries, K.M., Schlievert, P.M., et al. (1989) Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 321: 1-8.
37. Watanabe-Ohnishi, R., Low, D.E., McGeer, A., Stevens, D.L., Schlievert, P.M., Newton, D., et al. (1995) Selective depletion of VB-bearing T cells in patients with severe invasive group A streptococcal infections and streptococcal toxic shock syndrome. J Infect Dis 171: 74-84.
38. Wessels, M.R., and Bronze, M.S. (1994) Critical role of the group A streptococcal capsule in pharyngeal colonization and infection in mice. Proc Natl Acad Sci USA 91: 12238-12242.
39. Wessels, M.R., Moses, A.E., Goldberg, J.B., and DiCesare, T.J. (1991) Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci. Proc Natl Acad Sci USA 88: 8317-8321.
40. Wessels, M.R., Goldberg, J.B., Moses, A.E., and DiCesare, T.J. (1994) Effects on virulence of mutations in a locus essential for hyaluronic acid capsule expression in group A streptococci. Infect Immun 62: 433-441.
41. Wexler, D.E., Chenoweth, E.D., and Cleary, P.P. (1985) Mechanism of action of the group A streptococcal C5a inactivator. Proc Natl Acad Sci USA 82: 8144-8148.